Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor β1

Cancer Research

Volumn 56, Issue 6, 1996, Pages 1272-1278

  Wörner, Wolfgang ^a   Schrenk, Dieter ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; N (2 FLUORENYL)ACETAMIDE; PHENOBARBITAL; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; HUMAN; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CULTURE; MALE; PRIORITY JOURNAL; RAT; TUMOR SUPPRESSOR GENE; ULTRAVIOLET IRRADIATION;

2-ACETYLAMINOFLUORENE; ANIMALS; APOPTOSIS; CARCINOGENS; DNA DAMAGE; LIVER; LYMPHOTOXIN-ALPHA; MALE; NEOPLASM PROTEINS; RATS; RATS, WISTAR; TETRACHLORODIBENZODIOXIN; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0029878895     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Williams, G T. Programmed cell death: apoptosis and oncogenesis. Cell, 65: 1097-1098, 1991.
2. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T D., Land, H , Brooks, M., Waters, C M., Penn, L. Z , and Hancock, C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1993.
3. Moolgavkar, S., and Knudson, A. Mutation and cancer: a model for human carcinogenesis. J. Natl. Cancer Inst , 66: 1037-1052, 1981.
4. Rabes, H. M., Bücher, T., Hartmann, A., Linke, I., and Dunnwald, M. Clonal growth of carcinogen-induced, enzyme-deficient preneoplastic cell populations in mouse liver. Cancer Res., 42. 3220-3227, 1982.
5. Pilot, H C , and Sirica, A E. The stages of initiation and promotion in hepatocarcinogenesis. Biochim. Biophys. Acta, 605: 191-215, 1980
6. Schulte-Hermann, R. Tumour promotion in the liver Arch. Toxicol., 57 147-158, 1985.
7. Schulte-Hermann, R., Ohde, G , Schuppler, J., and Timmermann-Trosiener, I. Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumour promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin. Cancer Res., 41: 2556-2562, 1981.
8. Schulte-Hermann, R , Timmermann-Trosiener, I , Barthel, G., and Bursch, W. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res., 50. 5127-5135, 1990.
9. Bursch, W , Lauer, B., Timmermann-Trosiener, I., Barthel, G., Schuppler, J., and Schulte-Hermann, R. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumour promoters Carcinogenesis (Lond.), 5. 453-458, 1984.
10. Pitot, H. C., Goldsworthy, T., Campbell, H. A., and Poland, A Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res., 40: 3616-3620, 1980
11. Pitot, H. C., Goldsworthy, T. L , Moran, S., Kennan, W , Glauert, H. P , Maronpot, R R., and Campbell, H A A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci. Carcinogenesis (Lond.), 8: 1491-1499, 1987.
12. Schrenk, D., Buchmann, A., Dietz, K., Lipp, H-P., Brunner, H , Sirma, H , Munzel, P., Hagenmaier, H., Gebhardt, R., and Bock, K. W Promotion of pre-neoplastic foci in rat liver with 2,3,7,8-tetrachlordibenzo-p-dioxin,1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin, and a defined mixture of 49 polychlorinated dibenzo-p-dioxins. Carcinogenesis (Lond ), 15: 509-515, 1994.
13. Fox, T. R., Best, L. L., Goldsworthy, S. M , Mills, J. J., and Goldsworthy, T L. Gene expression and cell proliferation in rat liver after 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure. Cancer Res., 53. 2265-2271, 1993.
14. Schrenk, D., Karger, A., Lipp, H-P., and Bock, K W. 2,3,7,8-Tetrachlorodibenxo-p-dioxin and ethinylestradiol as comitogens in cultured rat hepatocytes Carcinogenesis (Lond.), 13: 453-456, 1992.
15. Stinchcombe, S., Buchmann, A., Bock, K. W., and Schwarz, M. Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver. Carcinogenesis (Lond.), 16: 1271-1275, 1995.
16. Kastan, M. B., Zhan, Q , El-Diery, W S., Carrier, F , Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell, 71: 587-597, 1992.
17. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl Acad. Sci. USA, 89: 7491-7495, 1992.
18. Oberhammer, F. A., Pavelka, M., Sharma, S , Tiefenbacher, R., Purchio, A. F., Bursch, W., and Schulte-Hermann, R. Induction of apoptosis in cultured hepatocytes and in repressing liver by transforming growth factor β1. Proc. Natl. Acad. Sci. USA, 89: 5408-5412, 1992.
19. Bursch, W , Oberhammer, F , and Schulte-Hermann, R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol. Sci., 13: 245-251, 1992.
20. Liebermann, D. A., Hoffman, B., and Steinman, R. A. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene, 11: 199-210, 1995.
21. Collins, M. K. L., Perkins, G. R., Rodriguez-Tarduchy, G., Nieto, M. A., and Lopez-Rivas, A. Growth factors as survival factors: regulation of apoptosis. Bioessays, 16. 133-138, 1994.
22. Massague, J. The transforming growth factor-β family. Annu. Rev. Cell Biol., 6: 597-641, 1990.
23. Tsukidate, K , Yamamoto, K., Snyder, J. W., and Farber, J. L. Mictrotubule antagonists activate programmed cell death (apoptosis) in cultured rat hepatocytes. Am. J. Pathol, 143: 918-925, 1993.
24. Wyllie, A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (Lond.), 284: 555-556, 1980.
25. 2+ in toxic cell killing. Trends Pharmacol. Sci., 10: 281-285, 1989.
26. Maeda, S., Kimura, H., Koga, N., Lin, K. H., and Saito, T Cell density-dependent DNA fragmentation and its suppression by heparin in primary culture of adult rat hepatocytes Biochem Biophys. Res. Commun., 195: 270-275, 1993.
27. Bayly, A. C., Roberts, R A., and Dive, C. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin J Cell Biol., 125: 197-203, 1994.
28. Kaneko, Y , and Tsukamoto, A. Apoptosis and nuclear levels of p53 protein and proliferating cell nuclear antigen in human hepatoma cells cultured with tumour promoters. Cancer Lett , 91: 11-17, 1995.
29. Wyllie, A H. Death gets a brake. Nature (Lond.), 369: 272-273, 1995.
30. Jayaraman, L., and Prives, C. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus Cell, 81: 1021-1029, 1995
31. Lee, S , Elenbaas, B., Levine, A., and Griffith, J. P53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell, 81: 1013-1020, 1995.
32. Kastan, M B., Onyekwere, O., Sidranyky, D., Vogelstein, B., and Craig, R W Participation of p53 protein in the cellular response to DNA damage. Cancer Res , 51: 6304-6311, 1991.
33. Fritsche, M., Haessler, C., and Brandner, G. Induction of nuclear accumulation of the tumor suppressor protein p53 by DNA-damaging agents. Oncogene, 8: 307-318, 1993.
34. El-Diery, W. S , Tokino, T., Velculescu, V. E , Levy, D. B., Parson, R., Trent, J M , Lin, D , Mercer, W E., Kinder, K. W., and Vogelstein, B. WAF1, a potential mediator of the p53 tumor suppression. Cell, 75: 817-825.
35. Perry, M. E., Piette, J , Zawadzki, J. A., Harvey, D., and Levine, A. The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl. Acad. Sci. USA, 90, 11623-11627, 1993.
36. Tsuji, K., and Ogawa, K. Recovery from ultraviolet-induced growth arrest of primary rat hepatocytes by p53 antisense oligonucleotide treatment. Mol. Carcinog., 9: 167-174, 1994.
37. Enan, E., and Matsumura, F. Evidenve for a second pathway in the action mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Biochem. Pharmacol , 49: 249-261, 1995.
38. Schrenk, D., Schafer, S , and Bock, K. W. 2,3,7,8-Tetrachlorodibenzo-p-dioxin as growth modulator in mouse hepatocytes with high and low affinity Ah receptor Carcinogenesis (Lond.), 15: 27-31, 1994.